Sign In
Buy MLSS
$0.399
+0.0080 (+2.05%)
At Close: Jul 31, 2026
Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe
08:30am, Tuesday, 30'th Jul 2024
ROSELAND, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
ROSELAND, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
11:00am, Tuesday, 18'th Jun 2024
Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain
Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript
08:56pm, Thursday, 16'th May 2024
Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
07:00am, Thursday, 16'th May 2024
Sales through new online portal increase 31% over the same period last year Gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year Reports steady progre
Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call
08:30am, Monday, 13'th May 2024
ROSELAND, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, tod
Milestone Scientific Inc. (MLSS) Q4 2023 Earnings Call Transcript
02:43pm, Monday, 01'st Apr 2024
Milestone Scientific Inc. (MLSS) Q4 2023 Earnings Call Transcript
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023
07:00am, Monday, 01'st Apr 2024
Reports acceleration of reimbursement claims submission for the CompuFlo® Epidural System Technology Reports acceleration of reimbursement claims submission for the CompuFlo® Epidural System Technol
Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call
11:45am, Thursday, 28'th Mar 2024
ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, t
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians
08:30am, Thursday, 14'th Mar 2024
Follows successful evaluation by Omaha Pain Physicians' founder and medical director, Dr. Matthew Stottle, reporting 100% success Follows successful evaluation by Omaha Pain Physicians' founder and me
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio
08:30am, Wednesday, 28'th Feb 2024
ROSELAND, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod
ROSELAND, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod
Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update
08:30am, Tuesday, 16'th Jan 2024
Reports initial reimbursements of CompuFlo® by commercial payors and Medicare Reports initial reimbursements of CompuFlo® by commercial payors and Medicare
PRISM Emerging MedDevices Mover Spotlight: Milestone Scientific Inc. (MLSS)
05:53pm, Wednesday, 27'th Dec 2023
New York, December 27, 2023 – Milestone Scientific Inc. (NYSE:MLSS) has established itself in the field of biomedical technology with its focus on advanced injection technologies for medical and den
Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock
05:00pm, Wednesday, 13'th Dec 2023
ROSELAND, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
